SCYNEXIS INC (SCYX)

Kritische 8-K Meldungen

WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (20.04.2026)
DatumMeldungSchwereFilingAuszug
20.04.2026Item 5.02 — Abgang SchlüsselpersonenHOCHSECof the Exchange Act. ☐     Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of C

Stammdaten

SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of various fungal infections, including recurrent VVC, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections; and ibrexafungerp that has completed Phase 3 CANDLE study for the prevention of recurrent (VVC). It has research collaborations with Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, and R-Pharm, CJSC to develop and commercialize rights for ibrexafungerp. The company was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. SCYNEXIS, Inc. was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Unternehmen & Branche

NameSCYNEXIS INC
TickerSCYX
CIK0001178253
BoerseUS
SektorHealthcare
IndustrieDrug Manufacturers - Specialty & Generic
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP811292101
ISINUS8112921015
TypCommon Stock
Marktkapitalisierung41,8 Mio. USD
Beta1,15
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K20,601,000-8,609,000-0.1759,027,00049,376,000
2025-09-3010-Q334,000-8,591,000-0.1751,071,00036,430,000
2025-06-3010-Q1,364,000-6,885,000-0.1460,694,00044,467,000
2025-03-3110-Q257,000-5,391,000-0.1167,915,00050,532,000
2024-12-3110-K3,746,000-21,288,000-0.4490,643,00055,077,000
2024-09-3010-Q660,000-2,808,000-0.0699,038,00058,529,000
2024-06-3010-Q736,000-14,458,000-0.30107,806,00060,406,000
2024-03-3110-Q1,373,000411,0000.01118,254,00074,105,000
2023-12-3110-K140,141,00067,041,0001.39128,412,00072,962,000
2023-09-3010-Q1,761,000-1,757,000-0.04148,546,00091,991,000
2023-06-3010-Q131,454,000122,260,0002.46154,856,00093,078,000
2023-03-3110-Q1,130,000-33,876,000-0.7170,296,000-29,914,000
2022-12-3110-K5,091,000-62,809,000-1.4787,810,0003,233,000
2022-12-3110-Q-62,800,00087,810,0003,233,000
2022-09-3010-Q1,557,000-29,584,000-0.62112,293,00017,209,000
2022-06-3010-Q1,323,000-13,345,000-0.31135,612,00045,480,000
2022-03-3110-Q687,000-5,451,000-0.18111,562,00038,927,000
2021-12-3110-K13,163,000-32,866,000-1.25119,837,00041,258,000
2021-09-3010-Q516,000-605,000-0.06109,882,00037,614,000
2021-06-3010-Q01,658,000-0.22121,131,00032,320,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
Avidity Partners Management LP2,081,66002,081,6601,316,442Neu+100,0%
GOLDMAN SACHS GROUP INC1,984,56101,984,5611,255,036Neu+100,0%
VANGUARD GROUP INC1,762,32201,762,3221,113,787Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC449,2230449,223284,145Neu+100,0%
BlackRock, Inc.334,6480334,648211,631Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC176,0000176,000111,302Neu+100,0%
BRIDGEWAY CAPITAL MANAGEMENT, LLC163,9370163,937103,674Neu+100,0%
STATE STREET CORP120,7300120,73076,350Neu+100,0%
CITADEL ADVISORS LLC103,9330103,93365,727Neu+100,0%
NORTHERN TRUST CORP75,454075,45447,717Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP51,015051,01532,262Neu+100,0%
LPL Financial LLC47,980047,98030,343Neu+100,0%
MORGAN STANLEY46,095046,09529,150Neu+100,0%
RAYMOND JAMES FINANCIAL INC33,395033,39521,119Neu+100,0%
UBS Group AG23,533023,53314,873Neu+100,0%
PDS Planning, Inc15,000015,0009,486Neu+100,0%
JANE STREET GROUP, LLC14,892014,8929,418Neu+100,0%
Creative Planning12,633012,6337,989Neu+100,0%
Pingora Partners LLC12,000012,0007,589Neu+100,0%
SIMPLEX TRADING, LLC4,00004,0002,529Neu+100,0%
US BANCORP \DE\3,10003,1001,960Neu+100,0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO2,48702,4871,573Neu+100,0%
BANK OF AMERICA CORP /DE/1,89101,8911,195Neu+100,0%
Tower Research Capital LLC (TRC)1,80601,8061,142Neu+100,0%
OSAIC HOLDINGS, INC.1,73001,7301,092Neu+100,0%
CITIGROUP INC1,37901,379872Neu+100,0%
HighMark Wealth Management LLC1,06601,066674Neu+100,0%
ACADIAN ASSET MANAGEMENT LLC583,1140583,114367Neu+100,0%
MAI Capital Management5000500317Neu+100,0%
Cornerstone Planning Group LLC3000300232Neu+100,0%
SBI Securities Co., Ltd.2320232147Neu+100,0%
GSA CAPITAL PARTNERS LLP160,9830160,983102Neu+100,0%
SageView Advisory Group, LLC3903925Neu+100,0%
CWM, LLC19101910Neu+100,0%
ROYAL BANK OF CANADA69206920Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
Avidity Partners Management LP2,081,6601,316,44227.65
GOLDMAN SACHS GROUP INC1,984,5611,255,03626.36
VANGUARD GROUP INC1,762,3221,113,78723.40
GEODE CAPITAL MANAGEMENT, LLC449,223284,1455.97
BlackRock, Inc.334,648211,6314.45
RENAISSANCE TECHNOLOGIES LLC176,000111,3022.34
BRIDGEWAY CAPITAL MANAGEMENT, LLC163,937103,6742.18
STATE STREET CORP120,73076,3501.60
CITADEL ADVISORS LLC103,93365,7271.38
NORTHERN TRUST CORP75,45447,7171.00
SUSQUEHANNA INTERNATIONAL GROUP, LLP51,01532,2620.68
LPL Financial LLC47,98030,3430.64
MORGAN STANLEY46,09529,1500.61
RAYMOND JAMES FINANCIAL INC33,39521,1190.44
UBS Group AG23,53314,8730.31
PDS Planning, Inc15,0009,4860.20
JANE STREET GROUP, LLC14,8929,4180.20
Creative Planning12,6337,9890.17
Pingora Partners LLC12,0007,5890.16
SIMPLEX TRADING, LLC4,0002,5290.05

Hinweis

Erweitert ×